The Response to September 11: A Disaster Case Study

Background: The response to 9/11 continues into its 14th year. The World Trade Center Health Program (WTCHP), a long-term monitoring and treatment program now funded by the Zadroga Act of 2010, includes >60,000 World Trade Center (WTC) disaster responders and community members (“survivors”). The...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Michael A. Crane, Nomi C. Levy-Carrick, Laura Crowley, Stephanie Barnhart, Melissa Dudas, Uchechukwu Onuoha, Yelena Globina, Winta Haile, Gauri Shukla, Fatih Ozbay
Formato: article
Lenguaje:EN
Publicado: Ubiquity Press 2014
Materias:
Acceso en línea:https://doaj.org/article/a23144841b2940b3892d3e3d72560662
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Background: The response to 9/11 continues into its 14th year. The World Trade Center Health Program (WTCHP), a long-term monitoring and treatment program now funded by the Zadroga Act of 2010, includes >60,000 World Trade Center (WTC) disaster responders and community members (“survivors”). The aim of this review is to identify several elements that have had a critical impact on the evolution of the WTC response and, directly or indirectly, the health of the WTC-exposed population. It further explores post-disaster monitoring efforts, recent scientific findings from the WTCHP, and some implications of this experience for ongoing and future environmental disaster response. Findings: Transparency and responsiveness, site safety and worker training, assessment of acute and chronic exposure, and development of clinical expertise are interconnected elements determining efficacy of disaster response. Conclusion: Even in a relatively well-resourced environment, challenges regarding allocation of appropriate attention to <a title="Learn more about Vulnerable Populations" href="https://www.sciencedirect.com/topics/medicine-and-dentistry/vulnerable-populations">vulnerable populations</a> and integration of treatment response to significant medical and mental health comorbidities remain areas of ongoing programmatic development.